期刊
CURRENT PHARMACEUTICAL DESIGN
卷 23, 期 23, 页码 3325-3341出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1381612823666170601101644
关键词
Polyamines; parasites; Trypanosoma brucei; Trypanosoma cruzi; Leishmania; Plasmodium; therapeutic strategies
资金
- National Institute of Allergy and Infectious Disease [AI041622]
- American Heart Association [0950095G]
There is an urgent need for the identification and validation of new therapeutic targets in protozoan parasites because currently available drugs are limited in number and usefulness, and no vaccines are available. The discovery that alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, is an efficacious treatment for African Sleeping Sickness caused by the protozoan parasite Trypanosoma brucei, has validated the polyamine pathway as a target in protozoan parasites. Polyamines are ubiquitous organic cations that play critical roles in key cellular processes such as growth, differentiation, and macromolecular biosynthesis. In recent years, remarkable progress has been made in the characterization of the polyamine pathway in a variety of protozoan parasites and this review will highlight surprising and unique features that could lead to new therapeutic strategies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据